Creative Planning’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Creative Planning’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,429	Closed	-$50K	–	2475
2022 Q2	$50K	Buy	1,429 +215	+18%	+$6.71K	﹤0.01%	2056
2022 Q1	$49K	Buy	1,214 +900	+287%	+$38.6K	﹤0.01%	2062
2021 Q4	$13K	Buy	+314	New	+$19.6K	﹤0.01%	2052
2017 Q3	–	Sell	-29	Closed	-$10K	–	3893
2017 Q2	$10K	Buy	+29	New	+$8.68K	﹤0.01%	3643
2015 Q4	–	Sell	-1	Closed	–	–	4630
2015 Q3	$0	Buy	+1	New	+$278	﹤0.01%	4376

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's DMK Position: Q3 2022 in Review

Creative Planning sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2022, closing a stake of 1,429 shares — an estimated $50K sold.

Creative Planning first reported a position in DMK in Q3 2015 and held it in 5 quarters. The position peaked at $50K in Q2 2022. 43 funds tracked by Wall St. Rank hold DMK as of Q3 2022.

Creative Planning reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2022 after selling out during the quarter.
Creative Planning sold 1,429 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2022, an estimated $50K.
Creative Planning first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2015 and held it in 5 quarters.
Creative Planning's DMK Pharmaceuticals Corporation Common Stock position peaked at $50K in Q2 2022.
43 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2022.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.